Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pain 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia 1

Interventions

Cyclophosphamide 47fludarabine phosphate 46Peripheral Blood Stem Cell Transplantation 36Tacrolimus 34Antilymphocyte Serum 33Busulfan 32Mycophenolic Acid 31Filgrastim 24Cyclosporine 24Radiotherapy 22Methotrexate 20Whole-Body Irradiation 18Methylprednisolone 18Melphalan 18Cord Blood Stem Cell Transplantation 14fludarabine 12Etoposide 11Granulocyte Colony-Stimulating Factor 8sargramostim 7Alemtuzumab 7Sirolimus 6Psychiatric Rehabilitation 6Flow Cytometry 6Cytarabine 6Rituximab 4Prednisone 4Polymerase Chain Reaction 4Immunologic Techniques 4thymoglobulin 3Thiotepa 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Baclofen × Myeloid × Clear all
NCT00516503 2017-08-24

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
208 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Pain, Neurotoxicity Syndromes, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡